TSX closed
Loading markets…

Advertisement

Stocks

What's Going On With BioNeutra Global Corp Stock Sunday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:BGA.V

Get BGA alerts:

Photos provided by Pexels

BioNeutra Global Corp has seen no movement in its stock price this week as it navigates significant regulatory challenges.

This week, BioNeutra Global Corp (BGA.V) maintained its position at C$0.03, reflecting no change in price over the past week. The company is currently facing a cease trade order from the British Columbia Securities Commission due to delays in filing its audited financial statements.

Investor takeaway: Investors should be cautious regarding BioNeutra Global Corp as it deals with regulatory issues and declining revenue trends. The company's financial health appears precarious, and further developments will be crucial for future performance.

Advertisement

BioNeutra Global Corp

BGA.V

Full stock page →

BGA.V

BioNeutra Global Corp

Source:WealthAwesomeWealthAwesome
$0.00 (0.00%)
120 day period
$0.03$0.53$0.03Dec 30Apr 8Jul 3

Market cap

$1.39M

52W high

$0.03

52W low

$0.03

1W change

+0.00%

Beta

0.98

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BGA's historical volatility

HistoricalForecast68%95%
C$0.03C$0.03C$0.03C$0.03C$0.03C$0.03TodayFeb 20Apr 29Jul 3Aug 15Sep 28Nov 10

30-Day Vol

0.0%

Annualized

90-Day Vol

0.0%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.03

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.03C$0.03C$0.03
60 trading daysC$0.03C$0.03C$0.03
90 trading daysC$0.03C$0.03C$0.03

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

BioNeutra's Market Cap Declines to C$1.39 Million

The company's market capitalization has shrunk significantly from C$20.62 million in 2015, signaling long-term financial challenges.

Bull case

If BioNeutra can resolve its cease trade order and enhance its financial reporting, it may regain investor confidence and stabilize its revenue.

Bear case

Ongoing financial difficulties and failure to address regulatory concerns could lead to further declines in stock price and potential insolvency risks.

Current Price Action

As of the latest trading session, BioNeutra Global Corp's stock closed at C$0.03, with no change in price observed over the past day, week, or month. This stability comes amid significant challenges for the company, including a cease trade order.

Recent Company News

Advertisement

BioNeutra Global Corp is currently under a cease trade order issued by the British Columbia Securities Commission. This order was imposed due to the company's delays in filing its audited annual financial statements for the fiscal year ended December 31, 2024. The company cited unforeseen complexities in the audit process as the reason for the delay and has committed to resolving the matter expediently. Investors are advised to stay updated on this situation as it develops.

Technical Picture

BioNeutra's stock is currently trading at its 50-day and 200-day moving averages of C$0.03, indicating a lack of upward momentum. The stock has a beta of 0.98, suggesting that it moves in line with the broader market. With a market capitalization of approximately C$1.39 million and a profit margin of -5.6%, the company's financial health appears concerning. The stock's 52-week range has not been specified, but the consistent price level indicates limited volatility.

Insider Activity

No recent insider activity has been reported for BioNeutra Global Corp, reflecting a lack of engagement from company insiders during this period of regulatory scrutiny.

Price Action Summary

BioNeutra Global Corp closed at C$0.03, with no percentage change noted in the last trading session. Investors should monitor the stock closely as the company addresses its regulatory challenges.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 14, 2026
Last Updated: September 14, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement